Hope for diabetes: CRISPR-edited cells evade immune detection
Elie Dolgin • September 5, 2025
Edits create cells that don’t trigger an immune response, allowing implant recipient to forego immune-suppressing drugs.
In a medical first, researchers report that they have implanted CRISPR-edited pancreas cells into a person with type 1 diabetes. The cells pumped out sugar-regulating insulin for months — without the need for the recipient to take immune-dampening drugs, thanks to gene edits that allowed the cells, collected from a deceased donor, to evade detection by the recipient’s immune system.
Continue reading at Nature.
Fresh treatments shift the focus from symptom management to repair.
Smart algorithms take aim at antimicrobial resistance.